Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Quantum-Si Incorporated - Class A Common Stock (NQ:QSI)

1.388 +0.318 (+29.74%)
Delayed Quote Updated: 12:07 PM EDT, Oct 1, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Quantum-Si Incorporated - Class A Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
11 12 Next >
Thursday's session: gap up and gap down stocks ↗
Via Chartmill
These stocks are moving in today's session ↗
Via Chartmill
News headline image
Quantum-Si Presents Interim Proteus™ Data at World HUPO 2026 Demonstrating a Significant Step Change in Performance Compared to Platinum® Pro
All measurable sequencing metrics show profound improvement over Platinum Pro 
From Quantum-Si Incorporated
Via GlobeNewswire
News headline image
Quantum-Si Announces Detection of 18 Amino Acids Using a Developmental Sequencing Kit on Proteus™
Milestone continues the progress towards detection of all 20 amino acids by end of 2026 
From Quantum-Si Incorporated
Via GlobeNewswire
Quantum-Si (QSI) Reports Q1 2026 Revenue Miss but Beats EPS Amid Proteus Launch Preparations ↗
Via Chartmill
News headline image
Quantum-Si Expands Proteus™ Roadshow with Additional U.S. and European Cities
Growing Multi-City Program Continues to Increase Awareness of Proteus and Support Customer Funnel Development Ahead of Commercial Launch 
From Quantum-Si Incorporated
Via GlobeNewswire
News headline image
Quantum-Si (QSI) Q2 2026 Earnings Call Transcript ↗
Proteus launch delayed to Q2 2027 as company cuts costs and eyes $4B market opportunity. 
Via The Motley Fool
Topics Earnings
News headline image
Quantum-Si to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
From Quantum-Si Incorporated
Via GlobeNewswire
News headline image
Quantum-Si Q2 Earnings Call Highlights ↗
Quantum-Si (NASDAQ:QSI) said it has moved the planned launch of its Proteus protein sequencing platform to the second quarter of 2027 from the end of 2026, citing the need for an additional integrated... 
Via MarketBeat
Topics Earnings
News headline image
Full Transcript: Quantum-Si Q2 2026 Earnings Call ↗
Quantum-Si (NASDAQ:QSI) reported second-quarter financial results on Thursday. The transcript from the company's second-quarter earnings call has been provided below. This transcript is brought to you... 
Via Benzinga
Topics Earnings
News headline image
Quantum-Si Reports Second Quarter 2026 Financial Results and Provides Proteus™ Development Update
From Quantum-Si Incorporated
Via GlobeNewswire
News headline image
Quantum-Si to Report Second Quarter 2026 Financial Results on August 13, 2026
From Quantum-Si Incorporated
Via GlobeNewswire
News headline image
Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Quantum-Si Incorporated
Via Business Wire
News headline image
Quantum-Si and Cell Signaling Technology Partner to Advance Post-Translational Modification Analysis on Proteus™
From Quantum-Si Incorporated
Via Business Wire
News headline image
Quantum-Si Announces the Expansion of the Proteus™ Roadshow
From Quantum-Si Incorporated
Via Business Wire
News headline image
Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Quantum-Si Incorporated
Via Business Wire
News headline image
Quantum-Si Q1 Earnings Call Highlights ↗
Quantum-Si (NASDAQ:QSI) reported first-quarter 2026 revenue of $258,000 and reiterated that the year will be a transition period focused on development and market preparation for its next-generation... 
Via MarketBeat
Topics Earnings
News headline image
Quantum-Si (QSI) Q1 2026 Earnings Transcript ↗
Quantum-Si (QSI) Q1 2026 Earnings Transcript 
Via The Motley Fool
News headline image
Quantum-Si Reports First Quarter 2026 Financial Results and Highlights Proteus™ Development Milestones
From Quantum-Si Incorporated
Via Business Wire
News headline image
Quantum-Si to Participate in the H.C. Wainwright 4th Annual BioConnect Investor Conference at NASDAQ
From Quantum-Si Incorporated
Via Business Wire
News headline image
Quantum-Si Announces Successful Sequencing on Integrated Proteus™ Instruments
From Quantum-Si Incorporated
Via Business Wire
News headline image
Forget Neuralink: The Real Brain Tech Trade Has 10 Names You’ve Never Heard ↗
The real brain computer interface opportunity isn’t in the headlines. These 10 stocks are building the systems that make it possible. 
Via InvestorPlace
Topics Artificial Intelligence Economy Initial Public Offering
News headline image
Quantum-Si to Report First Quarter 2026 Financial Results on May 7, 2026
From Quantum-Si Incorporated
Via Business Wire
News headline image
Quantum-Si Announces Two Customer Posters to be Presented at the American Association of Cancer Research Annual Meeting
From Quantum-Si Incorporated
Via Business Wire
News headline image
Quantum-Si Announces New Manuscript Demonstrating the Value of Single-molecule Protein Sequencing to Aid in Identifying New Cancer Treatment Strategies
From Quantum-Si Incorporated
Via Business Wire
News headline image
Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Quantum-Si Incorporated
Via Business Wire
News headline image
Quantum-Si Announces First Customer Samples Tested on the Proteus™ Prototype System
From Quantum-Si Incorporated
Via Business Wire
News headline image
Quantum-Si Announces the Start of the Proteus™ Roadshow
From Quantum-Si Incorporated
Via Business Wire
News headline image
Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Quantum-Si Incorporated
Via Business Wire
News headline image
Quantum-Si (QSI) Q4 2025 Earnings Call Transcript ↗
Quantum-Si (QSI) Q4 2025 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings
< Previous 1 2 3 4 5 6 7 8 9
...
11 12 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.